Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. 醫學院
  3. 醫學系
Please use this identifier to cite or link to this item: https://scholars.lib.ntu.edu.tw/handle/123456789/532755
Title: Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases
Authors: UN-IN WU 
Wang J.-L.
Chen W.-C.
SHAN-CHWEN CHANG 
YEE-CHUN CHEN 
Issue Date: 2011
Journal Volume: 30
Journal Issue: 1
Start page/Pages: 33-39
Source: European Journal of Clinical Microbiology and Infectious Diseases
Abstract: 
To determine whether there are differences in risk factors and outcomes among patients with E. coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum beta-lactamases. From 1 July 2005 to 30 June 2007, patients with positive blood culture of extended-spectrum β-lactamases (ESBL)-producing E. coli were reviewed. Sixty patients with ESBL-producing E. coli bacteremia were identified. These included 41 (68.3%) isolates with CTX-M β-lactamases. CTX-M-14 accounted for 31 (75.6%) and CTX-M-3 for 9 (22.0%) of the 41 CTX-M isolates. Patients with CTX-M strains were less likely, by univariate analysis, to have significant risk factors for infection including age?65 years, chronic renal insufficiency, ICU stay at bacteremia onset, central venous catheter use and mechanical ventilation. Multivariate analysis revealed that chronic renal failure and ICU stay were independent predictors. Antibiograms were similar for CTX-M and non-CTX-M producers except that CTX-M strains were significantly more susceptible to cefmetazole (92.7 vs 36.8%, p<0.0001). The overall mortality and length of hospitalization were not significantly different between the two groups. E. coli with CTX-M β-lactamases was more likely than non-CTX-M strains to invade non-compromised patients. There were no differences in clinical outcomes between the two groups. ? 2010 Springer-Verlag.
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78751567921&doi=10.1007%2fs10096-010-1048-2&partnerID=40&md5=ac6d75b2f9348ffaa9cbf3c0418af2d1
https://scholars.lib.ntu.edu.tw/handle/123456789/532755
ISSN: 0934-9723
DOI: 10.1007/s10096-010-1048-2
SDG/Keyword: amikacin; amoxicillin plus clavulanic acid; beta lactam antibiotic; beta lactamase CTX M; beta lactamase CTX M 14; beta lactamase CTX M 3; beta lactamase inhibitor; beta lactamase SHV; carbapenem derivative; cefazolin; cefmetazole; cefotaxime; ceftazidime; ceftriaxone; cephalosporin derivative; cephamycin; ciprofloxacin; ertapenem; extended spectrum beta lactamase; gentamicin; piperacillin plus tazobactam; quinoline derived antiinfective agent; unclassified drug; abdominal infection; adolescent; adult; antibiotic sensitivity; article; artificial ventilation; bacterial metabolism; bacterial strain; bacterial virulence; blood culture; central venous catheterization; chronic kidney failure; communicable disease; controlled study; enzyme synthesis; Escherichia coli infection; female; Gram negative sepsis; hospital infection; human; intensive care unit; length of stay; major clinical study; male; mortality; multiplex polymerase chain reaction; nonhuman; outcome assessment; priority journal; risk factor; strain difference; urinary tract infection; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Female; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome
[SDGs]SDG3
Appears in Collections:醫學系

Show full item record

SCOPUSTM   
Citations

17
checked on Mar 27, 2023

WEB OF SCIENCETM
Citations

14
checked on Mar 12, 2023

Page view(s)

25
checked on Apr 1, 2023

Google ScholarTM

Check

Altmetric

Altmetric

Related Items in TAIR


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback